
TOGETHER metformin trial retracted; COVID-OUT and ACTIV-6 still support metformin
The TOGETHER trial of metformin for early COVID-19 was retracted by its authors in October 2025 after an analysis error led to premature stopping. Louis notes that two other large randomized trials, COVID-OUT and ACTIV-6, independently showed metformin lowers long-COVID risk, and hopes for a corrected re-publication.

